UK has seen a significant jump in the number of product recalls and this is being linked to outsourcing to developing countries. Experts say that since most of the manufacturing is being outsourced to China and other nations it is becoming quite difficult to maintain control over quality.
The trade associations of US and Europe have taken a serious note of this issue and they are condemning the regulatory authorities for poorly regulating the foreign active pharmaceutical ingredient manufacturers. The pharma industry has taken the biggest hit in this regard.
As a result the credibility of the companies are taking the toll and with the market being highly completive they risk losing their customers and even their brand image could be hit badly. I believe the outsourcing companies should pull up their socks or risk losing their business as no company would like to sell products which start affecting their markets.
Via drugresearcher
